← 產業報告目錄
US Medical Second Opinion Market Research Report Information Based on Diagnosis (Cancer Cardiovascular disease, Spine Procedures, Neurology Conditions, Others), by Service Provider (Hospitals Physicians/Specialists, Medical Second Opinion Companies, Health Insurance Companies) by Mode of Payment (Online, Offline, and others) Forecast to 2030
授權報價
| Single User Price | $2,950 USD |
| Multi User Licence (up to 10 users) | $3,950 USD |
| Enterprisewide Price (Global Site License) | $5,250 USD |
報告摘要
US Medical Second Opinion Market Research Report Information Based on Diagnosis (Cancer Cardiovascular disease, Spine Procedures, Neurology Conditions, Others), by Service Provider (Hospitals Physicians/Specialists, Medical Second Opinion Companies, Health Insurance Companies) by Mode of Payment (Online, Offline, and others) Forecast to 2030
Market Overview
US Medical Second Opinion Market is anticipated to register a healthy CAGR of 116.11% during the review period. The growth of the US medical second opinion market is attributed to the growing preference for healthcare cost optimization, the increased need to improve diagnosis and treatment planning, and the increasing number of cancer cases. However, the high cost of a medical second opinion and lack of awareness among people is anticipated to hamper the market growth.
A second doctor's opinion is used to either confirm or change the recommendations made by another physician for a course of therapy. Getting a second medical opinion may have a substantial impact on the diagnosis, course of therapy, and prognosis. By maximizing the course of treatment, the patient can reduce unneeded risks. Less exposure to legal claims benefits doctors, and improved care, quality control, and cost savings from unneeded operations and treatments benefit healthcare organizations. However, using this technology improperly can result in exorbitant medical expenses.
Market Segmentation
Based on diagnosis the US Medical Second Opinion Market is classified into Cancer Cardiovascular disease, Spine Procedures, Neurology Conditions, Others.
In terms of Service Providers, the market has been categorized into Hospitals Physicians/Specialists, Medical Second Opinion Companies, Health Insurance Companies.
Based on Mode of Payment the market is divided into Online, Offline, and others.
Major Players
The key players in the US Medical Second Opinion Market are SecondOpinionExpert, Inc., Included Health, Inc., AccessHope, LLC, and 2nd.MD.
目錄 Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 9
1.1 OVERVIEW 9
2 MARKET INTRODUCTION 10
2.1 DEFINITION 10
2.2 SCOPE OF THE STUDY 10
2.3 RESEARCH OBJECTIVE 10
2.4 MARKET STRUCTURE 10
2.5 ASSUMPTIONS & LIMITATIONS 11
3 RESEARCH METHODOLOGY 12
3.1 DATA MINING 12
3.2 SECONDARY RESEARCH 13
3.3 PRIMARY RESEARCH 14
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 15
3.5 FORECASTING TECHNIQUES 16
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 17
3.6.1 BOTTOM-UP APPROACH 17
3.6.2 TOP-DOWN APPROACH 18
3.7 DATA TRIANGULATION 18
3.8 VALIDATION 18
4 MARKET DYNAMICS 19
4.1 OVERVIEW 19
4.2 DRIVERS 20
4.2.1 GROWING PREFERENCE FOR HEALTHCARE COST OPTIMIZATION 20
4.2.2 INCREASING NEED TO IMPROVE DIAGNOSIS AND TREATMENT PLANNING 20
4.2.3 INCREASING NUMBER OF CANCER CASES 21
4.3 RESTRAINTS 22
4.3.1 HIGH COST OF MEDICAL SECOND OPINION 22
4.3.2 LACK OF AWARENESS AMONG PEOPLE 22
4.4 OPPORTUNITIES 23
4.4.1 RISING NUMBER OF STRATEGIC INITIATIVES 23
5 MARKET FACTOR ANALYSIS 24
5.1 VALUE CHAIN ANALYSIS 24
5.1.1 R&D 25
5.1.2 SERVICE 25
5.1.3 SALES AND MARKETING 25
5.1.4 CONTRACT MANAGEMENT 25
5.1.5 CUSTOMER SERVICE & SUPPORT 25
5.2 PORTER'S FIVE FORCES MODEL 26
5.2.1 THREAT OF NEW ENTRANTS 26
5.2.2 BARGAINING POWER OF SUPPLIERS 26
5.2.3 THREAT OF SUBSTITUTES 27
5.2.4 BARGAINING POWER OF BUYERS 27
5.2.5 INTENSITY OF RIVALRY 27
5.3 IMPACT OF COVID-19 ON THE US MEDICAL SECOND OPINION MARKET 27
5.3.1 IMPACT ON VALUE CHAIN 27
5.3.2 IMPACT ON DEMAND 27
5.3.3 IMPACT ON REGION 28
5.3.4 IMPACT ON KEY PLAYERS 28
6 US MEDICAL SECOND OPINION MARKET, BY DIAGNOSIS 29
6.1 OVERVIEW 29
6.2 CANCER 30
6.3 CARDIOVASCULAR/HEART DISORDERS 31
6.4 SPINE PROCEDURES 33
6.5 NEUROLOGY CONDITIONS 34
6.6 OTHERS 34
7 US MEDICAL SECOND OPINION MARKET, BY SERVICE PROVIDER 35
7.1 OVERVIEW 35
7.2 HOSPITALS PHYSICIANS/SPECIALTIES 36
7.3 ONLINE PHYSICIANS PORTAL 36
7.4 MEDICAL SECOND OPINION COMPANIES 36
7.5 HEALTH INSURANCE COMPANIES 36
8 US MEDICAL SECOND OPINION MARKET, BY MODE OF PAYMENT 37
8.1 OVERVIEW 37
8.2 ONLINE PAYMENT 38
8.3 OFFLINE PAYMENT 38
9 COMPANY PROFILES 39
9.1 SECONDOPINIONEXPERT, INC. 39
9.1.1 COMPANY OVERVIEW 39
9.1.2 FINANCIAL OVERVIEW 39
9.1.3 PRODUCTS OFFERED 39
9.1.4 KEY DEVELOPMENTS 39
9.1.5 SWOT ANALYSIS 40
9.1.6 KEY STRATEGIES 40
9.2 INCLUDED HEALTH, INC. 41
9.2.1 COMPANY OVERVIEW 41
9.2.2 FINANCIAL OVERVIEW 41
9.2.3 PRODUCTS OFFERED 41
9.2.4 KEY DEVELOPMENTS 41
9.2.5 SWOT ANALYSIS 42
9.2.6 KEY STRATEGIES 42
9.3 ACCESSHOPE, LLC 43
9.3.1 COMPANY OVERVIEW 43
9.3.2 FINANCIAL OVERVIEW 43
9.3.3 PRODUCTS OFFERED 43
9.3.4 KEY DEVELOPMENTS 43
9.3.5 SWOT ANALYSIS 44
9.3.6 KEY STRATEGIES 44
9.4 NAVVISA 45
9.4.1 COMPANY OVERVIEW 45
9.4.2 FINANCIAL OVERVIEW 45
9.4.3 SERVICES OFFERED 45
9.4.4 KEY DEVELOPMENTS 45
9.4.5 KEY STRATEGIES 45
9.5 2ND.MD 46
9.5.1 COMPANY OVERVIEW 46
9.5.2 FINANCIAL OVERVIEW 46
9.5.3 SERVICES OFFERED 46
9.5.4 SWOT ANALYSIS 47
9.5.5 KEY DEVELOPMENTS 47
9.5.6 KEY STRATEGIES 47
10 APPENDIX 48
10.1 REFERENCES 48
10.2 RELATED REPORTS 49
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 11
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 14
TABLE 3 US: MEDICAL SECOND OPINION MARKET, BY DIAGNOSIS, 2018–2030 (USD MILLION) 29
TABLE 4 US: MEDICAL SECOND OPINION MARKET, FOR CANCER, BY TYPE, 2018–2030 (USD MILLION) 30
TABLE 5 US: MEDICAL SECOND OPINION MARKET, FOR CANCER, BY TYPE, 2018–2030 (UNITS) 30
TABLE 6 US: MEDICAL SECOND OPINION MARKET, FOR OTHER CANCER, BY TYPE, 2018–2030 (USD MILLION) 31
TABLE 7 US: MEDICAL SECOND OPINION MARKET, FOR CARDIOVASCULAR/HEART DISORDERS, BY TYPE, 2018–2030 (USD MILLION) 32
TABLE 8 US: MEDICAL SECOND OPINION MARKET, FOR CARDIOVASCULAR/HEART DISORDERS, BY TYPE, 2018–2030 (UNITS) 32
TABLE 9 US: MEDICAL SECOND OPINION MARKET, FOR SPINE PROCEDURES, BY TYPE, 2018–2030 (USD MILLION) 33
TABLE 10 US: MEDICAL SECOND OPINION MARKET, FOR NEUROLOGY CONDITIONS, BY TYPE, 2018–2030 (USD MILLION) 34
TABLE 11 US: MEDICAL SECOND OPINION MARKET, BY SERVICE PROVIDER, 2018–2030 (USD MILLION) 35
TABLE 12 US: MEDICAL SECOND OPINION MARKET, BY MODE OF PAYMENT, 2018–2030 (USD MILLION) 37
TABLE 13 SECONDOPINIONEXPERT, INC.: SERVICES OFFERED 39
TABLE 14 INCLUDED HEALTH, INC.: SERVICES OFFERED 41
TABLE 15 INCLUDED HEALTH, INC.: KEY DEVELOPMENTS 41
TABLE 16 ACCESSHOPE, LLC: SERVICES OFFERED 43
TABLE 17 ACCESSHOPE, LLC: KEY DEVELOPMENTS 43
TABLE 18 NAVVISA: SERVICES OFFERED 45
TABLE 19 2ND.MD: SERVICES OFFERED 46
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS 9
FIGURE 2 US MEDICAL SECOND OPINION MARKET 10
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 17
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE US MEDICAL SECOND OPINION MARKET 19
FIGURE 5 DRIVER IMPACT ANALYSIS 21
FIGURE 6 RESTRAINT IMPACT ANALYSIS 22
FIGURE 7 VALUE CHAIN ANALYSIS: US MEDICAL SECOND OPINION MARKET 24
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: US MEDICAL SECOND OPINION MARKET 26
FIGURE 9 US: MEDICAL SECOND OPINION MARKET, BY DIAGNOSIS, 2021 & 2030 (USD MILLION) 29
FIGURE 10 US: MEDICAL SECOND OPINION MARKET, BY SERVICE PROVIDER, 2021 & 2030 (USD MILLION) 35
FIGURE 11 US: MEDICAL SECOND OPINION MARKET, BY MODE OF PAYMENT, 2021 & 2030 (USD MILLION) 37
FIGURE 12 SECONDOPINIONEXPERT, INC.: SWOT ANALYSIS 40
FIGURE 13 INCLUDED HEALTH, INC.: SWOT ANALYSIS 42
FIGURE 14 ACCESSHOPE, LLC: SWOT ANALYSIS 44
FIGURE 15 2ND.MD: SWOT ANALYSIS 47
提及公司
SecondOpinionExpertInc.Included HealthInc.AccessHopeLLCand 2nd.MD.
同分類最新報告（醫療與生命科學）
查看醫療與生命科學全部報告 →
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們